Myriad Genetics, Inc. - Common Stock (NQ:MYGN)
Price and Volume
Detailed Quote| Volume | 1,801,507 |
| Open | 4.620 |
| Bid (Size) | 4.300 (900) |
| Ask (Size) | 4.580 (100) |
| Prev. Close | 4.580 |
| Today's Range | 4.220 - 4.826 |
| 52wk Range | 2.740 - 8.590 |
| Shares Outstanding | 93,500,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
50.2% below 52-week high
4.280
2.7452W Low
8.5952W High
1 Week
11.3% below 1-week high
4.051W Low
4.831W High
Myriad Genetics, Inc. - Common Stock (MYGN) traded between $2.74 and $8.59 over the past 52 weeks and last traded at $4.28, 50.2% below its 52-week high. Over the past week it ranged between $4.05 and $4.83.
Past 12 Months
1W
+$0.05
1M
+$1.10
3M
-$1.75
6M
-$0.39
YTD
-$1.86
1Y
-$3.71
MYGN was -46.4% over the past year, -8.4% over six months, -30.3% year to date, +1.2% in the last week.
12 Months vs Market
MYGN
-46.4%
DIA
+10.2%
SPY
+16.0%
QQQ
+25.0%
IWM
+14.0%
Over the past 12 months MYGN returned -46.4% versus DIA (Dow) +10.2%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +25.0% and IWM (Russell 2000) +14.0%.
Volume & Liquidity
0.91× 3-mo avg
Today 1,801,507
3-mo avg 2.0M
1W
1.9M
1M
2.2M
3M
2.0M
6M
1.8M
YTD
1.8M
1Y
1.6M
MYGN most recently traded 1,801,507 shares against a 3-month average daily volume of 2.0M.
More News
Read More
3 Reasons MYGN is Risky and 1 Stock to Buy Instead
September 24, 2026
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
September 17, 2026
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
September 16, 2026
2 Unprofitable Stocks to Research Further and 1 We Find Risky
September 15, 2026
Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)
September 07, 2026
Why Myriad Genetics (MYGN) Stock Is Down Today
September 01, 2026
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm
August 18, 2026
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks
August 17, 2026
3 Healthcare Stocks with Open Questions
August 10, 2026
Myriad Genetics Q2 Earnings Call Highlights ↗
July 31, 2026
Top movers in Friday's session ↗
July 31, 2026
Why Myriad Genetics (MYGN) Shares Are Falling Today
July 31, 2026
Top stock movements in today's session. ↗
July 31, 2026
Frequently Asked Questions
Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 4.280
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 10/06/26 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 400.18M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 400M shares outstanding.